E(1F&k2G(1F&l1H&n11WdLetterhead&l7C&a200CType=%(Type)s;npat=%(npat)s;pfx=%(pfx)s  ;pnom=%(pnom)s             ;prn=%(prn)s              ;cmed=%(cmed)s;numdos=1%(cprl)s507612 ;gmed=    ;
&a200Cnommed=%(nommed)s       ;adm1=%(adm1)s                        ;
&a200Cadm2=%(cprl)s rue Flor{al                          ;adm3=%(adm3)s                          ;datedos=%(datedos)s;
&a200Cccor=        ;nomcor=                                        ;
&a-4R(s0p10h12v0s0b3T(1F                                                                    (s0p16h8.v0s0b3T(1F p1/1  (s0p10h12v0s0b3T(1F 






&a12R
                                            %(nommed)s       
                                            %(adm1)s                        
                                            %(cprl)s rue Flor{al                          
  %(pfx)s   %(pnom)s %(prn)s                       %(adm3)s                
  NJF:                    DN:01/06/33
  %(ad1)s              
  %(ad2)s                              Besan\on, le %(datedos)s @ 13H31
  Dossier N[ 1%(cprl)s507612 du(s0p10h12v0s3b3T(1F %(datedos)s                                        (s0p10h12v0s0b3T(1F 


    (s1p16v0s4101T(1F                                           B I O C H I M I E       (s0p10h12v0s0b3T(1F
   (s0p16h8.v0s0b3T(1F                              (Analyseur VITROS 250 -ORTHO-CLINICAL DIAGNOSTICS)        (s0p10h12v0s0b3T(1F
                                                         (s0p16h8.v0s0b3T(1F  R{f{rence           Ant{rieurs        (s0p10h12v0s0b3T(1F
                                                                        (s0p16h8.v0s0b3T(1F05/03/14 (s0p10h12v0s0b3T(1F
   CREATININE . . . . . . . . . .       12,0 mg/l      (s0p16h8.v0s0b3T(1F    7,0 @ 13,0    (s0p10h12v0s0b3T(1F      (s0p16h8.v0s0b3T(1F   12,0 (s0p10h12v0s0b3T(1F
                                      106,20 umol/l    (s0p16h8.v0s0b3T(1F  61,95 @ 115,05  (s0p10h12v0s0b3T(1F
    (s0p16h8.v0s0b3T(1FTechnique enzymatique r{actifs ORTHO calibr{s/meth.de r{f.IDMS sur VITROS350 (s0p10h12v0s0b3T(1F
   Clairance cr{atinine MDRD           58,26 ml/mn








(s0p16h8.v0s0b3T(1F (s0p10h12v0s0b3T(1F 
(s0p16h8.v0s0b3T(1F  / (s0p10h12v0s0b3T(1F &a69R&a58C(s0p16h8.v0s0b3T(1F r{sultats RECTOVERSO(s0p10h12v0s0b3T(1F 
&a71R&a10C(s0p16h8.v0s0b3T(1F (s0p10h12v0s0b3T(1F &a71R&a33.5C(s0p16h8.v0s0b3T(1F Biologiste M{dical(s0p10h12v0s0b3T(1F &a71R&a61C(s0p16h8.v0s0b3T(1F J.ALMARCHA(s0p10h12v0s0b3T(1F               &a200Cff##